U.S. Government Hits HIV Drug Manufacturer With Patent Complaint

The transcript discusses a legal dispute between Gilead Sciences and the U.S. Department of Health and Human Services (HHS) over patents for HIV prevention drugs, Truvada and Descovy. HHS claims Gilead profited from these drugs without proper licensing, despite the patents being government-owned. Gilead has faced criticism for high drug prices and has requested a patent review, arguing the patents are invalid. The transcript also notes that 1.1 million people in the U.S. had HIV by the end of 2016.

What new insight or understanding did you gain from this video?